Key Statistics
Market Cap$36.61M
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.13
52W High$1.39
52W Low$0.50
SectorHEALTHCARE
IndustryMEDICAL DEVICES
Employees—
Price Performance
1 Week-1.69%
3 Month-12.44%
1 Year-41.11%
FinancialsAnnual · QuiverQuant
Revenue$36.35M
Assets$53.26M
Liabilities$29.99M
Net Income$28.51M loss
About
Cytosorbents Corporation, a critical care focused immunotherapy company, is dedicated to the research, development and commercialization of medical devices with its blood purification technology platform incorporating proprietary adsorbent and porous polymer technology. The company is headquartered in Monmouth Junction, New Jersey.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze CTSO with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.